Label: VETIVEX VETERINARY HYPERTONIC- sodium chloride injection, solution
- NDC Code(s): 17033-502-01
- Packager: Dechra Veterinary Products
- Category: PRESCRIPTION ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated November 19, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
-
Description:
Veterinary Hypertonic Saline Solution 7.2%, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for parenteral administration. It contains no antimicrobial agents. Discard unused portion.
Table 1 Hypertonic saline solution 7.2%, USP Size
(mL)Sodium Chlorine
(mg/mL)Osmolarity
(mEq/L)pH Sodium
(mEq/L)Chloride
(mEq/L)1000 7200 2464 (4.5 -7.0) 1232 1232 - Clinical Pharmacology:
- Indications and Usage:
-
Warnings:
This product contains no preservatives. Use entire contents when first opened. Discard any unused solution.
The parenteral administration of Veterinary Hypertonic saline solution 7.2%, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection.
In patients with diminished renal function, administration of Veterinary Hypertonic saline solution 7.2%, USP may result in sodium retention.
-
Adverse reactions:
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
-
Precautions:
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Caution must be exercised in the administration of Veterinary HYPERTONIC SALINE SOLUTION 7.2%, USP to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear, and seal is intact.
- Dosage and administration:
-
Overdosage:
In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures.
See Warnings, Adverse Reactions and Precautions.
- How Supplied:
-
Directions for use of plastic container
To open:
Tear overwrap downside at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.
Preparation for Administration:
- Suspend container from eyelet support.
- Remove protector from outlet port at bottom of container.
- Attach administration set. Refer to complete directions accompanying set.
To Add Medication
WARNING: Additives may be incompatible.
To add medication before solution administration:
- Prepare medication site.
- Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.
- Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.
To add medication during solution administration:
- Close clamp on the administration set to stop the flow to the patient.
- Prepare medication site.
- Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.
- Remove container from IV pole and/or turn to an upright position.
- Evacuate both ports by squeezing them while container is in the upright position.
- Mix solution and medication thoroughly.
- Return container to in-use position and continue administration.
- SPL UNCLASSIFIED SECTION
-
SPL UNCLASSIFIED SECTION
DISTRIBUTED BY:
Dechra Veterinary Products
7015 College Boulevard, Suite 525 Overland Park, KS 66211
Made in El Salvador.
For a copy of the Safety Data Sheet (SDS) or to report adverse reactions call
Dechra Veterinary Products at (866) 933-2472.
© 2021 Dechra Ltd.
Vetivex is a trademark of Dechra Ltd; all rights reserved.
REV07/21 -
PRINCIPAL DISPLAY PANEL - 1000 mL Container Label
Vetivex®
Hypertonic Saline
Solution 7.2%, USPSTERILE - NONPYROGENIC SOLUTION
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
CAUTION: FEDERAL LAW (U.S.A.) RESTRICTS
THIS DRUG TO USE BY OR ON THE ORDER OF A
LICENCED VETERINARIAN.
NDC: 17033-502-01INDICATIONS:
FOR USE IN REPLACEMENT THERAPY OF SODIUM, CHLORIDE
AND WATER WHICH MAY BECOME DEPLETED IN MANY DISEASES.DOSAGE AND ADMINISTRATION:
HORSES / CATTLE: 50 TO 100 ML PER 100 LB BODY
WEIGHT. WARM TO BODY TEMPERATURE AND ADMINISTER
SLOWLY BY INTRAVENOUS OR SUBCUTANEOUS INJECTION.
THE AMOUNT AND RATE OF ADMINISTRATION MUST BE
JUDGED BY THE VETERINARIAN IN RELATION TO THE
CONDITION BEING TREATED AND THE CLINICAL RESPONSE OF
THE ANIMAL, BEING CAREFUL TO AVOID OVERHYDRATION.COMPOSITION:
EACH 100 mL OF STERILE AQUEOUS SOLUTION CONTAINS 7.2 g
OF SODIUM CHLORIDE.MILLIEQUIVALENTS PER LITER:
CATIONS 1,232 mEq - ANIONS 1,232 mEq/L
TOTAL OSMOLARITY IS 2,464 MILLIOSMOLES PER LITER.
PH 4.5 - 7.0WARNING: THIS PRODUCT CONTAINS NO PRESERVATIVES.
USE ENTIRE CONTENTS WHEN FIRST OPENED. DISCARD
ANY UNUSED SOLUTION.STORAGE: EXPOSURE OF PHARMACEUTICAL PRODUCTS
TO HEAT SHOULD BE MINIMIZED. AVOID EXCESSIVE HEAT.
IT IS RECOMMENDED THE PRODUCT BE STORED IN
MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE
(25°C/77°F); BRIEF EXPOSURE UP TO 40°C/104°F DOES
NOT ADVERSELY AFFECT THE PRODUCT.DISTRIBUTED BY:
DECHRA VETERINARY PRODUCTS
7015 COLLEGE BOULEVARD, SUITE 525,
OVERLAND PARK, KS 66211MADE IN EL SALVADOR
STERILETAKE
TIME
OBSERVE LABEL
DIRECTIONSRev. 05/21
1000 mL
DechraLOT.0000000 EXP.00/0000
-
INGREDIENTS AND APPEARANCE
VETIVEX VETERINARY HYPERTONIC
sodium chloride injection, solutionProduct Information Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:17033-502 Route of Administration INTRAVENOUS, SUBCUTANEOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE 7.20 mg in 100 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:17033-502-01 1000 mL in 1 CONTAINER Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 12/01/2021 Labeler - Dechra Veterinary Products (362142734) Registrant - Dechra Ltd (641097493)